<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR44">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Norton</surname>
    <given-names>BL</given-names>
   </name>
   <name>
    <surname>Fleming</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Bachhuber</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Steinman</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>DeLuca</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Cunningham</surname>
    <given-names>CO</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Laraque</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Litwin</surname>
    <given-names>AH</given-names>
   </name>
  </person-group>
  <article-title>High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic</article-title>
  <source>Int J Drug Policy</source>
  <year>2017</year>
  <volume>47</volume>
  <fpage>196</fpage>
  <lpage>201</lpage>
  <pub-id pub-id-type="doi">10.1016/j.drugpo.2017.07.021</pub-id>
  <pub-id pub-id-type="pmid">28811158</pub-id>
 </element-citation>
</ref>
